Pear therapeutics ipo

Author: bumu

August undefined, 2024

WebApr 13, 2024 · Pear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) major shareholder 5Am Partners Iv, Llc sold 16,544,113 shares of the stock in a transaction on Monday, April 10th.The stock was sold at an average price of $0.12, for a total value of $1,985,293.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is … Web2024 IPO Pear Therapeutics Stock Digital Therapeutics Platform Founded 2013 Notable Investors Novartis Headquarters Boston MA, US Total Funding $274M About Pear Therapeutics Stock Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to help treat disease and enhance the efficacy of pharmaceuticals.

Netalie Nadivi sur LinkedIn : The unfortunate demise of Pear ...

WebPear Therapeutics discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Every day, we push the boundaries of technology to transform medicine. Pear has a pipeline of products and ... Webpeartherapeutics.com Healthcare Founded: 2013 Funding to Date: $139MM. Pear discovers, develops, and delivers clinically-validated software-based therapeutics to provide better … guttalax vaistai

Pear Therapeutics LinkedIn

WebThe transaction generated approximately $175 million in gross proceeds. Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics … WebFeb 2, 2024. February 02, 2024 08:00 AM Eastern Standard Time BOSTON-- ( BUSINESS WIRE )-- Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the Company will participate in the BTIG MedTech, Digital Health, Life … pilule pour kyste ovarien

Pear Therapeutics files for Chapter 11 bankruptcy

Pear Therapeutics NasdaqCM:PEAR Stock Report - Simply Wall St

WebApr 10, 2024 · Published: April 10, 2024 at 11:44 a.m. ET. By Colin Kellaher. Shares of Pear Therapeutics Inc. slid nearly 39% on Monday and a hit an all-time low after the developer of prescription digital ... WebApr 11, 2024 · Pear Therapeutics 2013年成立于美国，是一家基于软件的数字疗法平台提供商，致力于PDT（处方数字治疗）的研发工作。截至申请破产保护前，Pear共有三款数字疗法产品获批上市，分别针对药物使用障碍（ReSET）、阿片类药物使用障碍（ReSET-O）和慢性失眠（Somryst）。 guttalax onlineWebInvestors - Pear Therapeutics, Inc. pilule synthroid

"WebPear Therapeutics has raised a total of $409M in funding over 8 rounds. Their latest funding was raised on Dec 3, 2024 from a Post-IPO Equity round. Pear Therapeutics is registered … " - Pear therapeutics ipo

Pear therapeutics ipo

WebJun 22, 2024 · Pear Therapeutics, which has three FDA-authorized apps to treat psychiatric disorders, plans to go public in a $1.6 billion special purpose acquisition corporation, or … Webpeartherapeutics.com Healthcare Founded: 2013 Funding to Date: $139MM Pear discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Learn more about Pear Therapeutics IPO

Did you know?

WebJul 20, 2024 · Pear Therapeutics is a biotechnology and software company. It offers prescription digital therapeutics that that seek to manage or treat psychiatric and … WebJun 22, 2024 · – Pear Therapeutics, the leader in developing and commercializing prescription digital therapeutics to treat serious disease, and Thimble Point Acquisition …

WebNov 15, 2024 · The SPAC had also raised $276 million in a February IPO. A shareholder vote on the deal is set for Nov. 30. Pear develops prescription digital therapeutics (PDTs), which are software applications designed to collect real world data for use by prescribing clinicians and by payors and health systems for population health management. Read more. WebJan 3, 2024 · Our Class A Common Stock is listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “PEAR” and the Public Warrants are listed on Nasdaq under the symbol “PEARW”.On December 22, 2024, the last quoted sale price for the Pear Class A Common Shares as reported on Nasdaq was $5.98 per share and the last quoted sale price for our …

WebApr 13, 2024 · 4月7日，数字疗法企业Pear Therapeutics（下文简称Pear）宣布根据《美国破产法》第11章向美国特拉华地区破产法院提起自愿申诉，进入破产保护程序 ... WebDescription. Pear Therapeutics Inc is engaged in developing and commercializing software-based medicines, called prescription digital therapeutics. It focuses to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for ...

WebDec 8, 2024 · Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics …

WebApr 7, 2024 · April 7, 2024 By Sean Whooley. Pear Therapeutics (Nasdaq:PEAR) announced today that it filed for protection under Chapter 11 of the U.S. Bankruptcy Code. Boston-based Pear and its wholly-owned U.S ... pilule petite maison jauneWebJun 22, 2024 · TOKYO, June 22 (Reuters) - SoftBank-backed healthcare startup Pear Therapeutics has agreed to go public through a merger with Thimble Point Acquisition … guttalax valorWebThe unfortunate demise of Pear Therapeutics... This is what it might look like if you tried to move the Kilimanjaro to a new location, going against the wind… Netalie Nadivi sur LinkedIn : The unfortunate demise of Pear Therapeutics... gut talk